Clinical trial Recruiting at 1 site Interventional Ages 18 to 45 Women only

Postpartum acupressure education to support exclusive breastfeeding

Official title: Effect of Postpartum Acupressure Education on Breastfeeding Outcomes: A 12-Month Randomized Controlled Trial

Run by Nigde Omer Halisdemir University · NCT07410949 · Data updated 2026-11-12

Mothers who just gave birth will try a structured acupressure education program at home to see if it helps them exclusively breastfeed for 6 months, compared with standard postpartum care.

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexWomen only
Enrollment360 (estimated)
SponsorNigde Omer Halisdemir University
Academic / other
Locations1 site (Niğde, Merkez)
StatusRecruiting
StartedApril 25, 2026
Main results expectedFebruary 15, 2027
Study endsFebruary 15, 2027
Registry record updatedJune 2, 2026
Trial IDNCT07410949 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18–45 with term singleton birth, within 48 hours postpartum, who intend to breastfeed and can access smartphone-based materials in Turkish.

Probably not a fit

Women who cannot breastfeed due to medical reasons or who do not adhere to the education program may not experience a benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial tests whether teaching new mothers to self-administer acupressure improves exclusive breastfeeding rates at 6 months. Participants are randomized to receive acupressure education plus standard care or standard care alone, with education delivered face-to-face, via printed materials, and a short video. The primary outcome is exclusive breastfeeding at 6 months, using World Health Organization criteria; secondary outcomes include any breastfeeding at 12 months, self-efficacy, quality of breastfeeding, timing of complementary feeding, adverse events, and maternal satisfaction. Analyses follow an intention-to-treat approach across two parallel groups. Eligible participants are Turkish-speaking, NYC term singleton births (note: real site: Niğde, Turkey) aged 18-45, within 48 hours postpartum, intending to breastfeed, with access to a smartphone for materials and reminders.

Why it matters

Potential benefit: If successful, mothers may experience longer and higher-quality exclusive breastfeeding, potentially improving infant health and maternal confidence.

How similar studies have gone: Prior studies suggest education and self-care strategies can support breastfeeding, but evidence for acupressure education is limited and exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 to 45 years
* Term singleton birth (≥37 weeks of gestation)
* ≤48 hours postpartum at the time of enrollment
* Intention to breastfeed
* Ability to communicate in Turkish
* Access to a smartphone for educational materials and follow-up reminders
* Willingness to provide written informed consent

Exclusion Criteria:

* Contraindications to breastfeeding (e.g., infant galactosemia)
* Severe neonatal condition preventing breastfeeding
* Severe maternal medical or psychiatric condition interfering with breastfeeding
* Current opioid, alcohol, or substance dependence
* Multiple gestation pregnancy
* Severe breast injury or condition within the first 72 hours postpartum preventing breastfeeding

Where it's running

  • Niğde Ömer Halisdemir University Hospital
    Niğde, Merkez, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.